全基因组分析提供了乳腺癌对芳酶抑制反应的信息
Matthew J Ellis1, Li Ding, Dong Shen
1Department of Internal Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
Nature
|June 23, 2012
概括
雌激素受体阳性乳腺癌体内突变与明显的临床特征相关. 特定的基因突变,如MAP3K1和TP53,预测瘤亚型和治疗反应,指导未来的精准医学方法.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 雌激素受体阳性 (ER+) 乳腺癌表现出不同的临床特征.
- 了解这些变异的遗传基础对于向治疗至关重要.
研究的目的:
- 为了将ER+乳腺癌的临床特征与体质遗传改变相关联.
- 为了确定与瘤亚型相关的特定突变和对新辅助芳酶抑制剂治疗的反应.
主要方法:
- 对接受新辅助性芳香酶抑制剂治疗的患者治疗前瘤活检的分析.
- 大规模并行测序以识别关键基因中的体质突变.
主要成果:
- 鉴定了18个显著突变的基因,包括RUNX1,CBFB,MYH9,MLL3和SF3B1,其中一些先前与血液学疾病有关.
- 突变MAP3K1与光线A状态,低等级和低增殖有关,而突变TP53显示了相反的模式.
- 突变GATA3与在芳香酶抑制剂治疗期间抑制的增殖相关;MAP2K4突变模仿MAP3K1损失效应.
结论:
- 独特的ER+乳腺癌表型与影响细胞通路的特定体质突变模式有关.
- 虽然复发性突变很少发生,但它们为瘤生物学和潜在的治疗点提供了洞察力.
- 未来的临床试验需要全面的基因组测序来利用这些发现进行个性化治疗策略.
相关概念视频
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...